ClinicalTrials.govpublic full text
CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer
metastatic cancer, metastatic melanoma, renal cancer, clinical response, immunotherapy, adoptive cell therapy, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 832956
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.